
Biomonadic provides an AI platform that helps scientists and engineers optimize biotech manufacturing to increase yield and reduce process variability. It combines reinforcement learning and large language models to analyze process data, generate experimental strategies, and recommend operational adjustments. The product is a B2B SaaS platform for biomanufacturing teams and integrates with LIMS, process control systems, and data pipelines. Biomonadic targets biopharma and industrial biotech manufacturers aiming to scale and industrialize biologics production.

Biomonadic provides an AI platform that helps scientists and engineers optimize biotech manufacturing to increase yield and reduce process variability. It combines reinforcement learning and large language models to analyze process data, generate experimental strategies, and recommend operational adjustments. The product is a B2B SaaS platform for biomanufacturing teams and integrates with LIMS, process control systems, and data pipelines. Biomonadic targets biopharma and industrial biotech manufacturers aiming to scale and industrialize biologics production.
Company: Biomonadic
Product: AI-driven B2B SaaS platform to optimize biomanufacturing using reinforcement learning and LLMs
Founded: 2023
Stage / Funding: Pre-Seed (Pre-Seed round announced Mar 11, 2024)
Investors: Forum Ventures; Right Side Capital Management
Headquarters: Berkeley, CA
Optimizing biomanufacturing processes (cell- and gene-therapy manufacturing, biologics production) to increase yield and reduce variability.
2023
Biotechnology
145000 USD
Investors listed for the round: Forum Ventures and Right Side Capital Management
“Forum Ventures; Right Side Capital Management”